COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor
NCT04318366 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2026-05-08
Summary
Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions
Conditions
- Coronavirus Infections
Interventions
- OTHER
-
Observational Study
Not required
Sponsors & Collaborators
-
Università Vita-Salute San Raffaele
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-19
- Primary Completion
- 2026-06-19
- Completion
- 2026-06-19
Countries
- Italy
Study Locations
More Related Trials
-
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159 ·Status: RECRUITING
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Predictive Factors COVID-19 Patients
NCT04427345 ·Status: WITHDRAWN
-
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 ·Status: UNKNOWN
-
Assesment of the Metabolomic Signature in COVID-19 Patients
NCT04497272 ·Status: COMPLETED ·Phase: NA
-
Imaging Feature of SARS-CoV2 Infection
NCT04394026 ·Status: COMPLETED
-
S Protein and COVID-19: a Monocentric Prospective Study
NCT05351385 ·Status: RECRUITING
-
International SARS-CoV-2 (COVID-19) Infection Observational Study
NCT04385251 ·Status: COMPLETED
-
Independent Predictors on Clinical Outcomes in SARS-CoV2 Patients
NCT05162534 ·Status: COMPLETED
-
Understanding COVID-19
NCT04329546 ·Status: COMPLETED
-
Developement and Evaluation of Serological Assays for COVID-19
NCT04377763 ·Status: UNKNOWN
-
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886 ·Status: COMPLETED
-
Colchicine Counteracting Inflammation in COVID-19 Pneumonia
NCT04322565 ·Status: COMPLETED ·Phase: PHASE2
-
Predictive Immune Biomarkers for COVID-19 Pathogenesis
NCT04385108 ·Status: COMPLETED ·Phase: NA
-
C-reactive Protein Levels Among Individuals With COVID-19
NCT04373798 ·Status: COMPLETED
-
Sensitivity Evaluation of Serological Tests for Covid-19
NCT04678024 ·Status: UNKNOWN
-
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 ·Status: COMPLETED
-
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942 ·Status: COMPLETED
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
NCT04359667 ·Status: UNKNOWN
-
Study on the Performance and Safety of Sentinox in COVID-19 Patients
NCT04909996 ·Status: COMPLETED ·Phase: NA
-
Predictors of COVID-19 Infection and Disease Progression
NCT04484597 ·Status: UNKNOWN
-
FAst and SimplE COVID-19 Causing Virus SARS-CoV-2 Detection
NCT05341635 ·Status: COMPLETED
-
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373 ·Status: UNKNOWN
-
Prognostic Factors of COVID19
NCT04405726 ·Status: UNKNOWN